Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study

Abstract

ClinicalTrials.gov under the identifier NCT02085460 (the date of trial registration: March 11, 2014).